在持久性COPD使用者中,单个吸入器三重疗法与布德塞尼德/葡萄糖/甲醇酸盐的现实有效性:一项回顾性数据库研究
Bruno Sposato1, Leonardo Gianluca Lacerenza2, Sara Croce1
1Pneumology Department, Local Health Unit 'Toscana Sud-Est', 'Misericordia' Hospital, 58100 Grosseto, Italy.
Biomedicines
|November 27, 2025
概括
单吸入器三重疗法 (SITT) 用于布德尼德/形式醇/葡萄糖 (B/F/G) 显著减少了COPD患者的急诊和住院治疗. 长期使用也改善了肺功能,减少了对口服皮质类固醇和短效β-激动剂的需求.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 单吸入器三重疗法 (SITT) 为慢性阻塞性肺病 (COPD) 患者提供治疗选择,这些患者经常经历恶化.
- 布德索尼德/形式/甘皮龙 (B/F/G) 是本研究中评估的一种SITT配方.
研究的目的:
- 评估B/F/G在COPD患者的长期实践疗效.
- 主要终点包括急诊室访问和住院.
- 二级终点集中在肺功能,以及口服皮质类固醇 (OCs),抗生素和短效β-激动剂 (SABAs) 的处方.
主要方法:
- 一项追溯观察性研究,涉及65名患有复发性恶化慢性肺炎的患者.
- 在18-24个月的B/F/G治疗与前18-24个月使用的先前疗法 (LABA/LAMA,ICS/LABA,ICS/LABA + LAMA或其他SITT) 的比较.
- 分析的数据包括处方数据,恶化事件和肺功能参数 (FEV1%,FVC%).
主要成果:
- 与之前的治疗相比,B/F/G治疗与急诊室访问 (0.34对0.65) 和住院 (0.52对0.83) 的显著减少有关.
- 平均FEV1%在B/F/G治疗后得到改善 (48.5%对45%),尽管FVC%没有显著差异.
- 对OCs (2.96对3.86) 和SABAs (1.41对2.48) 的处方在B/F/G.中明显较低. 没有注意到抗生素处方的差异.
结论:
- 长期使用B/F/G在现实世界中证明了其有效性,减少了COPD恶化,OC和SABA的使用,并改善了肺功能.
- 患者高度坚持和坚持B/F/G治疗对于最大限度地提高治疗效益至关重要.
- 优化守是管理COPD患者以提高治疗结果的关键目标.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
Inhaled Medications
702
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
702
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K


